BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

GENpathway Inc. Announces Breakthrough Application Of Its Transcription Analysis Tools In Toxicogenomics And Pharmacogenomics


10/19/2005 5:13:03 PM

SAN DIEGO, March 17 /PRNewswire/ -- Genpathway, Inc. announced today that recently completed studies demonstrated the ability of TranscriptionPath(TM), a component of Genpathway's integrated suite of novel gene transcription analysis tools, to detect gene expression changes associated with toxic drug effects. Genpathway's tools measure the process of transcription directly, rather than accumulated RNA levels.

Genpathway presented these and other results involving specific applications of TranscriptionPath(TM) to toxicology and pharmaco/toxicogenomics at the 2005 Society of Toxicology Annual Meeting held in New Orleans.

Pharmacogenomic and toxicogenomic studies often require analysis of gene expression changes in tissues that were not frozen immediately, such as tissue from human cadavers or deceased animals held for hours under suboptimal conditions. Due to the inherent instability of RNA, evaluation of these tissues using RNA profiling, including conventional microarray analysis, has proved challenging.

"These studies demonstrate the significant value of Genpathway's suite of tools in enabling toxicologists to analyze tissues from animals and humans in basic toxicology and pharmaco/toxicogenomic applications with high reproducibility and sensitivity, including cases in which RNA is likely to be degraded," said Mary Warren, Chief Scientific Officer of Genpathway.

Genpathway's scientific presentation highlighted the results of studies involving analysis of postmortem tissues that had been stored under suboptimal conditions for up to 24 hours. Mice were initially dosed with compounds known to induce liver toxicity for varying amounts of time. Livers were assayed by TranscriptionPath(TM) and also for RNA levels using reverse-transcriptase PCR. Key findings included:

-- Levels of transcription measured in livers contained within animals stored for 24 hours (3 hours at room temperature plus 21 hours at 4 degrees C) prior to removal and analysis were similar to those found in tissue that was processed immediately. In contrast, RNA levels from the stored animal tissues were very low due to degradation. -- Mice dosed with the same compounds for up to 48 hours followed by processing of the livers under optimal conditions showed that TranscriptionPath(TM) detected gene expression changes with greater accuracy compared with measurement of RNA levels. The improvement was particularly striking with regard to the timing of the gene expression changes and the extent of those changes.

The results of these studies confirmed previously obtained results by the company showing that RNA degrades but transcription complexes are stable. The findings also demonstrated that, even for optimally processed tissues, TranscriptionPath(TM) determined gene expression changes associated with toxicology more accurately than RNA profiling-particularly with regard to timing of gene activation and repression, and the levels of those changes.

Genpathway's innovative tools -- TranscriptionPath(TM), FactorPath(TM) and PromoterPath(TM) -- can be used on any type of fresh or frozen cells or tissues from any species. The results of these studies may be found at http://www.genpathway.com/.

ABOUT GENPATHWAY, INC.

Genpathway is a systems biology company developing innovative tools that identify and analyze complex biological pathways to drive discovery and testing of novel pharmaceuticals, biomarkers and diagnostic tests. http://www.genpathway.com/

CONTACT: Mary Moynihan M2Friend Communications 802 951 9600 mary@m2friend.com

Genpathway, Inc.

CONTACT: Mary Moynihan, M2Friend Communications, +1-802-951-9600,mary@m2friend.com, for Genpathway, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES